Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.52
-0.28 (-3.18%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $606.54 million as of July 24, 2026. Its market cap has increased by 650.93% in one year.
Market Cap
606.54M
Enterprise Value
517.00M
1-Year Change
650.93%
Ranking
Category
Stock Price
$8.52
ChartMarket Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $606.54M, an increase of 822.58%. That is a compound annual growth rate of 62.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 606.54M | 120.08% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 626.22M |
| MiMedx Group | 625.57M |
| CorMedix | 617.42M |
| AgomAb Therapeutics NV | 616.09M |
| Nuvectis Pharma | 608.76M |
| Allogene Therapeutics | 600.57M |
| REGENXBIO | 600.37M |
| ARS Pharmaceuticals | 589.86M |